Success Stories

Event Videos

Gaucher Disease type 1 Source Event :Metabolic Liver Disease mid term INASL meeting - Jan 2012 organised by Children's Liver Foundation and IAP, Mumbai	Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis http://www.ncbi.nlm.nih.gov/pubmed/24168258 Di Marco V, Covolo L, Calvaruso V, Levrero M, Puoti M, Suter F, Gaeta GB, Ferrari C, Raimondo G, Fattovich G, Santantonio T, Alberti A, Bruno R, Mussini C, Mondelli M, Donato F, Craxì A; Multicenter Italian Group for the Study of Hepatitis C. Published on: Nov-2013 Read more
Galactosemia Source Event :Metabolic Liver Disease mid term INASL meeting - Jan 2012 organised by Children's Liver Foundation and IAP, Mumbai	The new paradigm of hepatitis C therapy: integration of oral therapies into best practices http://www.ncbi.nlm.nih.gov/pubmed/24168254 Afdhal NH, Zeuzem S, Schooley RT, Thomas DL, Ward JW, Litwin AH, Razavi H, Castera L, Poynard T, Muir A, Mehta SH, Dee L, Graham C, Church DR, Talal AH, Sulkowski MS, Jacobson IM; New Paradigm of HCV Therapy Meeting Participants. Published on: Nov-2013 Read more
Story of two siblings with “Chubby Cheeks” Source Event :Metabolic Liver Disease mid term INASL meeting - Jan 2012 organised by Children's Liver Foundation and IAP, Mumbai Presenter: Dr. Moinaksen Sarma Moderators: Dr. Anupam Sibal, Dr. K P Mehta, Dr. Priya Kishnani	Results of a stepwise approach to extrahepatic portal vein obstruction in children http://www.ncbi.nlm.nih.gov/pubmed/23783024 Alberti D, Colusso M, Cheli M, Ravelli P, Indriolo A, Signorelli S, FagiuoliS, D'Antiga L. Abstract BACKGROUND: The management of extrahepatic portal vein obstruction (EHPVO) in children is controversial. We report our experience with a prospective evaluation of a stepwise protocol based on severity of portal hypertension and feasibility of mesoportal bypass (MPB). Published on: Nov-2013 Read more
Metabolic Liver Disease Source Event :Metabolic Liver Disease mid term INASL meeting - Jan 2012 organised by Children's Liver Foundation and IAP, Mumbai Progressiv familial intrahepatic cholestasis type 1 case presentation from Sanjeev Kumar Read more	Percutaneous liver biopsy: pathologic diagnosis and complications in children http://www.ncbi.nlm.nih.gov/pubmed/23799457 Short SS, Papillon S, Hunter CJ, Stanley P, Kerkar N, Wang L, Azen C, Wang K. Abstract OBJECTIVE: The aim of this study was to determine patient factors that predict diagnostic failure or increased risk of bleeding complications following percutaneous liver biopsy in children. Published on: Nov-2013 Read more
α-fetoprotein levels after interferon therapy and risk of hepato-carcinogenesis in chronic hepatitis C http://www.ncbi.nlm.nih.gov/pubmed/23564522 Asahina Y, Tsuchiya K, Nishimura T, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, EnomotoN,Nakagawa M, Kakinuma S, Watanabe M, Izumi N. Published on: Nov-2013 Read more	Measurement of hepatic venous pressure gradient is feasible and safe in children http://www.ncbi.nlm.nih.gov/pubmed/23799453 Woolfson J, John P, Kamath B, Ng VL, Ling SC. Abstract BACKGROUND AND OBJECTIVES: Hepatic venous pressure gradient (HVPG) is an indirect measure of portal venous pressure in cirrhosis, which is valid in cirrhotic adults for evaluating the severity of portal hypertension, predicting outcomes, and guiding therapeutic decisions. Published data on the measurement of HVPG in children are sparse. The aim of the present study was to determine the feasibility and safety of undertaking HVPG measurements in children. Published on: Dec-2013 Read more

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube